Longitudinal follow-up with VIM thalamic deep brain stimulation for dystonic or essential tremor.


Journal

Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060

Informations de publication

Date de publication:
10 03 2020
Historique:
received: 21 04 2019
accepted: 10 09 2019
pubmed: 13 2 2020
medline: 9 7 2020
entrez: 13 2 2020
Statut: ppublish

Résumé

To assess longitudinal tremor outcomes with ventral intermediate nucleus deep brain stimulation (VIM DBS) in patients with dystonic tremor (DT) and to compare with DBS outcomes in essential tremor (ET). We retrospectively investigated VIM DBS outcomes for 163 patients followed at our center diagnosed with either DT or ET. The Fahn-Tolosa-Marin tremor rating scale (TRS) was used to assess change in tremor and activities of daily living (ADL) at 6 months, 1 year, 2-3 years, 4-5 years, and ≥6 years after surgery. Twenty-six patients with DT and 97 patients with ET were analyzed. Compared to preoperative baseline, there were significant improvements in TRS motor up to 4-5 years (52.2%; Overall, tremor control with VIM DBS in DT and ET was comparable and remained sustained at long term likely related to intervention at the final common node in the pathologic tremor network. However, the long-term ADL improvements in DT were not sustained, possibly due to inadequate control of concomitant dystonia symptoms. These findings from a large cohort of DT indicate that VIM targeting is reasonable if the tremor is considerably more disabling than the dystonic features. This study provides Class IV evidence that VIM DBS improves tremor in patients with DT or ET.

Identifiants

pubmed: 32047071
pii: WNL.0000000000008875
doi: 10.1212/WNL.0000000000008875
pmc: PMC7238918
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1073-e1084

Informations de copyright

© 2020 American Academy of Neurology.

Références

PLoS One. 2017 Sep 13;12(9):e0183711
pubmed: 28902876
Stereotact Funct Neurosurg. 2010;88(2):98-104
pubmed: 20197711
Neurology. 2018 Nov 20;91(21):e2020-e2026
pubmed: 30341158
Mov Disord. 2005 Mar;20(3):377-80
pubmed: 15580615
Brain. 2014 Jan;137(Pt 1):109-21
pubmed: 24277721
Mov Disord. 2008 Jun 15;23(8):1146-53
pubmed: 18442104
Brain. 2010 Dec;133(Pt 12):3635-48
pubmed: 20926368
Brain. 2012 May;135(Pt 5):1455-62
pubmed: 22344584
J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):474-482
pubmed: 30337440
Neurology. 2019 Mar 19;92(12):e1378-e1386
pubmed: 30787161
Parkinsonism Relat Disord. 2017 Jul;40:18-26
pubmed: 28400200
Neurology. 2000 Jun 27;54(12):2342-4
pubmed: 10881269
Stereotact Funct Neurosurg. 2009;87(6):379-84
pubmed: 19844137
J Neurol. 2011 Mar;258(3):434-9
pubmed: 20927533
Parkinsonism Relat Disord. 2016 Oct;31:23-27
pubmed: 27388270
J Neurol. 2015 Jun;262(6):1548-56
pubmed: 25929664
J Neurosurg. 2007 Nov;107(5):977-82
pubmed: 17977270
Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S87-S91
pubmed: 28747280
Mov Disord. 2014 Jun;29(7):928-34
pubmed: 24442708
Parkinsonism Relat Disord. 2016 Aug;29:3-9
pubmed: 27062584
Front Neurol. 2018 Jul 05;9:544
pubmed: 30026728
Brain. 2019 Jun 1;142(6):1644-1659
pubmed: 30957839
PLoS One. 2018 Jan 23;13(1):e0191359
pubmed: 29360867
Neuroscience. 2014 Feb 28;260:23-35
pubmed: 24333801
Curr Opin Neurol. 2018 Aug;31(4):455-461
pubmed: 29750732
Mov Disord. 2014 Jun;29(7):953-9
pubmed: 24752968
J Neurol. 2001 Aug;248(8):695-700
pubmed: 11569899
Mov Disord. 2018 Jan;33(1):75-87
pubmed: 29193359
Tremor Other Hyperkinet Mov (N Y). 2018 Jun 20;8:557
pubmed: 29971197
Brain. 2016 Nov 1;139(11):2948-2956
pubmed: 27658421
Parkinsonism Relat Disord. 2013 Jul;19(7):684-6
pubmed: 23611688
J Neurol Neurosurg Psychiatry. 2014 Jul;85(7):759-69
pubmed: 24167042
Nat Commun. 2017 Apr 04;8:14912
pubmed: 28374839
J Neurosurg. 2010 Dec;113(6):1230-3
pubmed: 20509725
J Neurol Neurosurg Psychiatry. 2005 May;76(5):684-90
pubmed: 15834027
J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):856-64
pubmed: 25280914
World Neurosurg. 2019 May;125:191-197
pubmed: 30738935
Mov Disord. 2013 Jun 15;28(7):863-73
pubmed: 23649720
Parkinsonism Relat Disord. 2019 Mar;60:126-132
pubmed: 30220556
Neurology. 2017 Sep 26;89(13):1416-1423
pubmed: 28768840
Clin Neurol Neurosurg. 2016 Nov;150:169-176
pubmed: 27685658
Parkinsonism Relat Disord. 2013 Jun;19(6):634-8
pubmed: 23523105

Auteurs

Takashi Tsuboi (T)

From the Department of Neurology, Norman Fixel Institute for Neurological Diseases (T.T., Z.J., P.R.Z., M.J.B., M.S.O., A.W.S.), and Department of Neurosurgery (K.D.F.), University of Florida, Gainesville, FL.

Zakia Jabarkheel (Z)

From the Department of Neurology, Norman Fixel Institute for Neurological Diseases (T.T., Z.J., P.R.Z., M.J.B., M.S.O., A.W.S.), and Department of Neurosurgery (K.D.F.), University of Florida, Gainesville, FL.

Pamela R Zeilman (PR)

From the Department of Neurology, Norman Fixel Institute for Neurological Diseases (T.T., Z.J., P.R.Z., M.J.B., M.S.O., A.W.S.), and Department of Neurosurgery (K.D.F.), University of Florida, Gainesville, FL.

Matthew J Barabas (MJ)

From the Department of Neurology, Norman Fixel Institute for Neurological Diseases (T.T., Z.J., P.R.Z., M.J.B., M.S.O., A.W.S.), and Department of Neurosurgery (K.D.F.), University of Florida, Gainesville, FL.

Kelly D Foote (KD)

From the Department of Neurology, Norman Fixel Institute for Neurological Diseases (T.T., Z.J., P.R.Z., M.J.B., M.S.O., A.W.S.), and Department of Neurosurgery (K.D.F.), University of Florida, Gainesville, FL.

Michael S Okun (MS)

From the Department of Neurology, Norman Fixel Institute for Neurological Diseases (T.T., Z.J., P.R.Z., M.J.B., M.S.O., A.W.S.), and Department of Neurosurgery (K.D.F.), University of Florida, Gainesville, FL.

Aparna Wagle Shukla (A)

From the Department of Neurology, Norman Fixel Institute for Neurological Diseases (T.T., Z.J., P.R.Z., M.J.B., M.S.O., A.W.S.), and Department of Neurosurgery (K.D.F.), University of Florida, Gainesville, FL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH